Pharmaceutical Latin

Aids to Pharmaceutical Latin

Aids to Pharmaceutical Latin is a small handbook of the Students Aid Series giving a concise account in English of Latin grammar, phrases, abbreviations, etc., used by pharmacists in general. The need for a book ?f this nature is perhaps not likely to be keenly felt at the present time, in view of the fact that the Latin terras used in medicine and pharmacy are being so largely replaced by dire...

Health and Ethical Consequences of Outsourcing Pivotal Clinical Trials to Latin America: A Cross-Sectional, Descriptive Study

INTRODUCTION The implications of conducting clinical trials in low and middle income countries on the financial accessibility and safety of the pharmaceutical products available in those markets have not been studied. Regulatory practices and ethical declarations lead to the commercialization of the new products, referred to as New Molecular Entities (NMEs), in the countries where tested as soo...

The World Bank, pharmaceutical policies, and health reforms in Latin America.

Health care systems spend a relatively high percentage of their resources on the purchase of medicines, and the poor spend a disproportionate amount of their income on pharmaceuticals. There is ample evidence in the literature that drugs are very poorly used. World Bank-led health reforms aim at improving equity, efficiency, quality, and users' satisfaction, and it will be difficult to achieve ...

Pharmaceutical Arithmetic and Latin Including Prescription Reading

Availability and affordability of new medicines in Latin American countries where pivotal clinical trials were conducted.

OBJECTIVE To assess whether new pharmaceutical products approved by the United States Food and Drug Administration (FDA) in 2011 and 2012 were registered, commercialized and sold at affordable prices in the Latin American countries where they were tested. METHODS We obtained a list of new molecular entities (new pharmaceutical products) approved by the FDA in 2011 and 2012. FDA medical review...